// App-Quantinova.ai

e21031 : PD-1 blockade in metastatic melanoma (MEL): The University of Pittsburgh experience.

Researchers

Presenter

  • Diwakar Davar

Principal Investigators

  • Ling Tian

  • Fei Ding

  • Cindy Sander

  • Ahmad A. Tarhini

  • John M. Kirkwood

Medical Centers

  • University of Pittsburgh Medical Center, Pittsburgh, PA

  • University of Pittsburgh, Pittsburgh, PA

  • University of Pittsburgh Cancer Institute, Pittsburgh, PA

  • Department of Medicine, University of Pittsburgh Medical Center, Pittsburgh, PA

Locations

  • United States

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Melanoma

Biomarkers

  • Programmed cell death protein 1

Drug/Treatment

  • Pembrolizumab

  • Nivolumab

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Final

Copyright © 2026. QuantiNova All rights reserved